AMA-0526

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameAMA-0526

Drug Alias NameRho associated protein kinase inhibitor (Amakem)AMA-0526

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRho-associated kinases inhibitors

TargetsRho-associated kinases

Therapy Area/IndicationsCorneal Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmakem Nv

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmakem Nv

Active IndicationsN/A

Inactive IndicationsCorneal Injuries

ATC CodeN/A